GlassScriptPhysician profile
Amanda G Jack
NPI 1982432316
$2,113.86
in general payments reported to CMS, 2019-2025
18 companies · $2,061 in 2025
The $2,061 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $53.36 · 2025: $2,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $509.49 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $313.06 | 2025 | Erleada |
| Boston Scientific Corporation | $285.73 | 2025 | Axonics, Spaceoar Vue System - 10ml |
| Valencia Technologies Corporation | $260.25 | 2025 | Ecoin Device Kit |
| Urogen Pharma, INC. | $136.22 | 2025 | |
| Pfizer INC. | $89.90 | 2025 | |
| Abbvie INC. | $88.77 | 2025 | |
| Axogen | $79.16 | 2025 | |
| Tolmar, INC. | $72.16 | 2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $61.42 | 2024-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $57.26 | 2025 | Keytruda, Welireg |
| Photocure INC | $29.82 | 2025 | Cysview |
| Procept Biorobotics Corporation | $28.50 | 2025 | |
| Inspire Medical Systems, INC. | $27.94 | 2025 | Inspire |
| Medtronic, INC. | $21.09 | 2025 | Interstim |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $19.12 | 2025 | Bioprotect Balloon Implant System |
| Alkermes, INC. | $17.34 | 2024 | Vivitrol |
| Azurity Pharmaceuticals, INC. | $16.63 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Jack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.